An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma

Clinical Research Alliance, New Hyde Park

Ospedale San Raffaele, Milan

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII), Bergamo

Leo Jenkins Cancer Center/ECU School of Medicine, Greenville

Hospital Universitario Ramon y Cajal, Madrid

Tampereen yliopistollinen sairaala, Tampere

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego, Wroclaw

The University of Texas MD Anderson Cancer Center, Houston

Renovatio Clinical, The Woodlands

Innovative Clinical Research Institute, Downey

Pacific Cancer Medical Center, Inc., Anaheim

Ventura County Hematology-Oncology Specialists, Oxnard

Summit Medical Group, Florham Park

Aarhus University Hospital, Aarhus

CHU Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand

Hôpital Henri Mondor, Créteil

Groupe Hospitalier Pitie-Salpetriere, Paris

CHU Poitiers - Hôpital la Milétrie, Poitiers

Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), Monza

KO-MED Centra Kliniczne, Biała Podlaska

Uniwersyteckie Centrum Kliniczne, Gdansk

Nasz Lekarz Przychodnie Medyczne, Torun

Hospital Universitari Vall d'Hebron, Barcelona

ICO Badalona - Hospital Universitari Germans Trias i Pujol, Barcelona

Institut Català d'Oncologia, Barcelona

Fundacion Jimenez Diaz, Madrid

Hospital Universitario Infanta Leonor, Madrid

Hospital Universitario Quironsalud Madrid, Madrid

MD Anderson Cancer Centre, Madrid

Hospital Universitario Virgen del Rocio, Seville

Hospital Universitario Virgen Macarena, Seville

Helsingin yliopistollinen keskussairaala, Helsinki